The mRNA's market is presently experiencing substantial growth, fueled by the successful deployment of mRNA-based vaccines against COVID-19. Studies reveal a complex landscape, with ongoing funding into therapeutic applications beyond infectious diseases, encompassing areas such as oncology, rare diseases, and protein replacement care. Geographic v